Home Your basket
• What is the effect of diz...
   Price 10.50 €
• Tuberculosis of the parot...
   Price 5.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Anterior cerebrospinal fl...
   Price 10.00 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Stuttering of the “Miror”...
   Price 5.50 €
• Positioning in the oropha...
   Price 8.50 €
• Nystagmus and vibratory t...
   Price 10.50 €
• Kikuchi's disease as the ...
   Price 10.50 €
• Endovascular treatment of...
   Price 12.00 €
• Middle ear overpressure w...
   Price 10.50 €
• The frontal pneumosinus d...
   Price 8.50 €
• Static management of lago...
   Price 10.50 €
• Treatment of severe epist...
   Price 5.50 €
• Is ethmoidal adenocarcino...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Total ossicular reconstru...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Parathyroid carcinoma: di...
   Price 5.50 €
• A rare and unusual cause ...
   Price 8.50 €
• Congenital nasal pyriform...
   Price 5.50 €
• Are we sectioning the coc...
   Price 10.50 €
• Comparison of radical (na...
   Price 10.50 €
• Validation of a clinical ...
   Price 10.50 €
• XVIth World Congress of O...
   Price 8.50 €
• Prevalence of sensineural...
   Price 14.00 €
• Rhinophyma in a black afr...
   Price 5.50 €
• An original case of laryn...
   Price 8.50 €
• Disorders of the sense of...
   Price 5.50 €
• A comparative study of br...
   Price 10.50 €
• Fistula of the fourth bra...
   Price 5.50 €
• Medical rhinoplasty conce...
   Price 14.00 €
• Endoscopic ligation of th...
   Price 12.00 €
• Notes on voice and speech...
   Price 8.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Non-functioning parathyro...
   Price 5.50 €
• The prevention of voice d...
   Price 10.50 €

Total Order 327.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2007 o

CANCER

Outcome of surgical and adjuvant radiotherapy treatment of T3-T4 squamous cell carcinoma of the floor of the mouth: evaluation of oncological control and treatment related morbidity


Authors : Hitter A, Soriano E, Bettega G, Karkas A, Reyt E, Righini C. A (Grenoble)

Ref. : Rev Laryngol Otol Rhinol. 2007;128,3:155-162.

Article published in french
Downloadable PDF document french



Summary : Objective: The aims of this study were to evaluate the therapeutic outcome and morbidity associated with management of squamous cell carcinoma (SCC) T3-T4 of the floor of the mouth. Patients and Methods: This was a retrospective study (1993 and 2005). Inclusion criteria were: 1) Presence of a locally advanced (T3-T4) lesion of the floor of the mouth; 2) Pathological confirmation of SCC; 3) No previous treatment of the floor of the mouth; 4) Absence of any synchronous lesions at the primary endoscopic work-up; 5) Absence of distant metastasis outside the aero-digestive tract; 6) Karnofsky performance index >70. All patients were treated by surgery and adjuvant radiotherapy. The statistical analysis was conducted using the stat-view software; categorical variables were compared using the Fisher’s exact test; analysis of recurrence-free survival rate was done following the Kaplan-Meier method, and the log-rank test was used for the comparison of survival graphs. Results: Fourty-seven patients were included in this study (42 men), of a mean age of 53.3 years. The majority of patients (93.6%) presented with a stage IVa tumour, and no clinical evidence of cervical lymphadenopathy in 60% of cases. All patients underwent bilateral neck dissection adapted to the cervical lymph node status. Forty-one (87%) patients underwent partial mandibulectomy with fibula free-flap reconstruction in 32 cases (78%). Early local complication rate was of 32%. The mean duration of hospitalization was 34 days. Late local complication rate was of 17%. The immediate post-operative death rate was 2%. The rate of survival and recurrence free survival was of 47.5% and 47% respectively. The 3 survival-influencing factors were age (p= 0.02), margins of surgical resection (p= 0.002), and histologic cervical lymph node status (p= 0.03). Conclusion: T3-T4 tumours of the floor of the mouth are managed by surgical resection and adjuvant radiotherapy. There is a high rate of treatment-associated complications. The prognosis of locally advanced tumours of the floor of the mouth remains humble.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE